BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 38525415)

  • 1. Prediction of High-Risk Neuroblastoma Among Neuroblastic Tumors Using Radiomics Features Derived from Magnetic Resonance Imaging: A Pilot Study.
    Kim J; Choi YH; Yoon H; Lim HJ; Han JW; Lee MJ
    Yonsei Med J; 2024 May; 65(5):293-301. PubMed ID: 38653568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing.
    Choi MH; Yoon SB; Lee YJ; Jung ES; Pak S; Han D; Nickel D
    Front Oncol; 2024; 14():1304187. PubMed ID: 38525415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging phenotype using
    Lim CH; Cho YS; Choi JY; Lee KH; Lee JK; Min JH; Hyun SH
    Eur J Nucl Med Mol Imaging; 2020 Aug; 47(9):2113-2122. PubMed ID: 32002592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rim Enhancement and Peripancreatic Fat Stranding in Preoperative MDCT as Predictors for Occult Metastasis in PDAC Patients.
    Bai X; Wu L; Dai J; Wang K; Shi H; Lu Z; Ji G; Yu J; Xu Q
    Acad Radiol; 2023 Dec; 30(12):2954-2961. PubMed ID: 37024338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Prediction after Curative Resection of Pancreatic Ductal Adenocarcinoma by Imaging-Based Intratumoral Necrosis.
    Kim H; Kim DH; Song IH; Kim B; Oh SN; Choi JI; Rha SE
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics models based on multi-sequence MRI for preoperative evaluation of MUC4 status in pancreatic ductal adenocarcinoma: a preliminary study.
    Deng Y; Li Y; Wu JL; Zhou T; Tang MY; Chen Y; Zuo HD; Tang W; Chen TW; Zhang XM
    Quant Imaging Med Surg; 2022 Nov; 12(11):5129-5139. PubMed ID: 36330180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.
    Suzuki T; Masugi Y; Inoue Y; Hamada T; Tanaka M; Takamatsu M; Arita J; Kato T; Kawaguchi Y; Kunita A; Nakai Y; Nakano Y; Ono Y; Sasahira N; Takeda T; Tateishi K; Uemura S; Koike K; Ushiku T; Takeuchi K; Sakamoto M; Hasegawa K; Kitago M; Takahashi Y; Fujishiro M;
    Cancer Sci; 2022 Sep; 113(9):3097-3109. PubMed ID: 35567350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS mutation allele frequency threshold alters prognosis in right-sided resected pancreatic cancer.
    Nauheim D; Moskal D; Renslo B; Chadwick M; Jiang W; Yeo CJ; Nevler A; Bowne W; Lavu H
    J Surg Oncol; 2022 Aug; 126(2):314-321. PubMed ID: 35333412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Pancreatic and Biliary Neoplasms with Small Biopsy-Based Next Generation Sequencing (NGS): Doing More with Less.
    Nikas IP; Mountzios G; Sydney GI; Ioakim KJ; Won JK; Papageorgis P
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053560
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.